BioMarin Pharmaceutical, Inc. (BMRN)
55.90
+0.31
(+0.56%)
USD |
NASDAQ |
Mar 26, 14:49
BioMarin Pharmaceutical Market Cap : 10.75B for March 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.529B |
| Ionis Pharmaceuticals, Inc. | 12.40B |
| Mirum Pharmaceuticals, Inc. | 5.393B |
| MannKind Corp. | 719.41M |
| Terns Pharmaceuticals, Inc. | 4.763B |
Market Cap Related Metrics
| PE Ratio | 31.37 |
| PS Ratio | 3.353 |
| Price to Book Value | 1.766 |
| Price to Free Cash Flow | 15.16 |
| Price | 55.90 |
| Earnings Yield | 3.19% |
| Operating PE Ratio | 13.30 |
| Normalized PE Ratio | 17.55 |